Aktien aus dem Gesundheitswesen
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 441 |  VNDA Vanda Pharmaceuticals Inc. | 7.2700 USD | -0.68% | -0.27% | -17.10% | +31.46% | 429.72 M USD | ||
| 442 |  ANGO AngioDynamics, Inc. | 10.3400 USD | -1.24% | +3.40% | -2.91% | -16.48% | 427.24 M USD | ||
| 443 |  ENTA Enanta Pharmaceuticals, Inc | 14.55 USD | -0.55% | +6.44% | +13.05% | +190.42% | 422.23 M USD | ||
| 444 |  RCKT Rocket Pharmaceuticals, Inc. Common Stock | 3.88 USD | +6.59% | +9.30% | -19.50% | -39.38% | 421.25 M USD | ||
| 445 |  AKBA Akebia Therapeutics, Inc. | 1.5500 USD | -0.64% | +9.15% | +4.73% | +31.36% | 415.21 M USD | ||
| 446 |  CLYM Climb Bio, Inc. Common Stock | 8.6500 USD | -2.26% | +22.00% | +22.35% | +58.14% | 413.19 M USD | ||
| 447 |  NAUT Nautilus Biotechnolgy, Inc. Common Stock | 3.25 USD | +6.21% | +4.17% | +37.71% | +322.08% | 411.33 M USD | ||
| 448 |  LCTX Lineage Cell Therapeutics, Inc. | 1.6350 USD | +2.83% | +6.17% | +4.14% | -4.78% | 407.26 M USD | ||
| 449 |  NRC National Research Corporation Common Stock (Delaware) | 17.84 USD | +4.69% | +3.48% | +8.52% | +65.03% | 405.80 M USD | ||
| 450 |  AUTL Autolus Therapeutics plc American Depositary Share | 1.49 USD | +0.68% | 0.00% | +2.76% | +5.67% | 396.55 M USD | ||
| 451 |  XFOR X4 Pharmaceuticals, Inc. Common Stock | 4.3300 USD | +3.10% | +7.71% | +18.96% | +45.79% | 393.68 M USD | ||
| 452 |  CERS Cerus Corp | 2.02 USD | +0.50% | +7.45% | +19.53% | +53.03% | 388.19 M USD | ||
| 453 |  PALI Palisade Bio, Inc. Common Stock | 2.3400 USD | +13.59% | +24.47% | +19.39% | +37.65% | 388.17 M USD | ||
| 454 |  MNPR Monopar Therapeutics Inc. Common Stock | 57.9100 USD | -0.02% | +1.01% | -4.07% | +6.02% | 387.54 M USD | ||
| 455 |  LAB Standard BioTools Inc. Common Stock | 0.98 USD | +10.11% | +3.16% | +5.38% | -14.78% | 382.27 M USD | ||
| 456 |  DCTH Delcath Systems Inc | 10.9900 USD | +1.01% | +12.72% | +14.60% | +6.29% | 381.86 M USD | ||
| 457 |  PBYI PUMA BIOTECHNOLOGY INC | 7.48 USD | -1.19% | +0.81% | +24.67% | +154.42% | 380.56 M USD | ||
| 458 |  ZNTL Zentalis Pharmaceuticals, Inc. Common Stock | 5.36 USD | +3.28% | +77.48% | +94.91% | +325.40% | 380.19 M USD | ||
| 459 |  NAGE Niagen Bioscience, Inc. Common Stock | 4.7400 USD | +1.07% | +4.64% | -1.66% | -4.82% | 379.58 M USD | ||
| 460 |  CABA Cabaletta Bio, Inc. Common Stock | 3.40 USD | +4.29% | +10.75% | +9.32% | +200.88% | 378.50 M USD |
Nachrichten Aktien aus dem Gesundheitswesen
Vivos Therapeutics, Inc. (VVOS) Q4 2025 Earnings Call Transcript
VFLO: Free Cash Flow + Growth Is A Winning Formula (NASDAQ:VFLO)
Vivos Therapeutics übertrifft Umsatz- und Gewinnprognosen für Q4 2025
Jefferies bekräftigt "Buy"-Rating für BridgeBio Pharma mit Kursziel 100 US-Dollar
Hims & Hers: BofA erhöht Kursziel aufgrund von Peptid-Chancen
Cytokinetics: CEO Robert I. Blum verkauft Aktien im Wert von 490.000 $
RA Capital verkauft Vor Biopharma-Aktien im Wert von 11,8 Mio. US-Dollar
Gainers Aktien aus dem Gesundheitswesen
 IMMP Immutep Limited American Depositary Shares | 0.54 | +74.19% |
 CUE Cue Biopharma, Inc. | 0.72 | +63.64% |
 NOTV Inotiv, Inc. Common Stock | 0.39 | +56.00% |
 NIVFW NewGenIvf Group Limited Class A ordinary shares | 0.0194 | +45.86% |
 CDTTW CDT Equity Inc. Common Stock | 0.0085 | +41.67% |
 NXGL NexGel, Inc Common Stock | 0.76 | +28.81% |
 PDSB PDS Biotechnology Corporation Common Stock | 1.36 | +28.30% |
 TSHA Taysha Gene Therapies, Inc. Common Stock | 6.00 | +27.39% |
Losers Aktien aus dem Gesundheitswesen
 WORX SC WORX Corp | 1.06 | -30.72% |
 CMND Clearmind Medicine Inc. Common Shares | 0.65 | -28.57% |
 BEAT Heartbeam, Inc. Common Stock | 0.89 | -25.83% |
 TALKW Talkspace, Inc. Common Stock | 0.0016 | -23.81% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0796 | -20.32% |
 JSPRW Jasper Therapeutics, Inc. Common Stock | 0.0166 | -20.19% |
 TOIIW The Oncology Institute, Inc. Common Stock | 0.0399 | -18.40% |
 ONCO Onconetix, Inc. Common Stock | 0.7615 | -16.32% |